Implementing an electronic end-of-life chemotherapy utilization measure Published March 2020 Citation Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ. . Journal of Oncology Practice. . http://ascopubs.org/doi/abs/10.1200/JOP.18.00408 Authors:Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ Sources:Journal of Oncology Practice Share Posted inPublicationsTreatment patterns More publicationsESMOOctober 2025Real-world treatment patterns and outcomes in US patients with neurotrophic tyrosine receptor kinase–positive solid tumorsSu, I, Flores Avile C, Huang P, et al. Publication summaryPublicationsTreatment patternsWorld Conference on Lung CancerAugust 2025Evolving treatment patterns in early-stage non-small cell lung cancer in the USGray J E, Thoele K, Gilligan A M, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world biomarker testing and treatment initiation in patients with resected early-stage NSCLC (eNSCLC) in the US and UKRinaldi C, Halloran S, Pittel H, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancer